-
KKR likely to buy Gland Pharma for Rs 1,000 crore by month-end
The deal would mean an exit for existing investor Evolvence…
Read more -
President Obama on ‘Patent Trolls’ May Spring Significant Change in Pharma Companies Strategies.
Intellectual Property (IP) has been a strategic tool for business…
Read more -
Breaking : India approves $1.6bn acquisition of Agila Specialties by Mylan
India’s government has given the go-ahead for US-based pharmaceutical company…
Read more -
Sanofi Inching Closer to Rs 2,400 crore Deal with Elder Pharma Domestic Business
Sanofi close to acquiring Elder Pharma’s local biz Sources say…
Read more -
Pharmaceutical manufacturing units on verge of closure
Faced with lack of marketing support from the State Government,…
Read more -
-
We expect Indian pharma companies to generate strong revenues from the US generic market due to the receipt of many ANDA approvals from US FDA
We expect Indian pharma companies to generate strong revenues from…
Read more -
Cadila, Torrent surge Ahead for Merger
MUMBAI: Even as the shares of Indian pharmaceutical companies are…
Read more -
India needs to revisit its bilateral investment treaties programme to ensure that multilateral gains on patents are not lost
India needs to revisit its bilateral investment treaties programme to…
Read more -